Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

Canna Care Docs

DECEMBER 16, 2020

Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. What conditions is medical marijuana helpful for? While research is ongoing, existing studies and anecdotal evidence show that medical cannabis is useful for a variety of conditions, both physical and psychiatric.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

CannaMD

AUGUST 19, 2020

The CDC notes that individuals of all ages may contract COVID-19; however, the risk of death is significantly higher for older populations and those with underlying health conditions. Hypothesizing that high-CBD cannabis extracts may be used to modulate ACE2 expression in COVID- 19 target tissues, researchers went to work.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

Freedom Leaf

OCTOBER 15, 2018

This move reinforced a federal ruling on April 16 that affirmed the December 2016 DEA decision to create a new Schedule I code for cannabis extracts, including CBD extracts. On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome).

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Raphael Mechoulam inspired a wave of investigation into the therapeutic properties of cannabis, as well as its derivatives and extracts. . by the year 2027 , at which point the market could be worth a staggering $33.2

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. In 2020, the others segment accounted for the highest share in the market, owing to the increasing utilization of minor cannabinoids for health conditions.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

MAY 10, 2019

This oil is made after extracting CBD from the cannabis plant. To answer this question in short, Yes, CBD is legal, but under certain conditions. People suffering from pain, or conditions that can only be treated with Cannabidiol, vaping oil proves to be the best in that case giving instant relief.

Vaping 45

Vaping Oil CBD Epilepsy 45

Cannabis Law Report

MAY 19, 2022

According to FDA, because the cannabis plant contains naturally low levels of Delta-8 THC, some manufacturers use potentially unsafe household chemicals in potentially unsanitary conditions to produce the substance through synthesis. Studies Show Our Whole-Spectrum Extract Utilizing CBD.Can Prevent Infection From COVID-19.”.

THC 52

THC CBD Food Pets 52

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

CannaMD

SEPTEMBER 15, 2020

Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. SHORT ANSWER: Full-time and seasonal Florida residents who suffer from an eligible medical condition. Regular cannabis does not have to meet the same requirements. Crohn’s Disease.

Law 126

Law Marijuana Patients Treatment 126

CannaTech

OCTOBER 14, 2018

The bill, scheduled to take effect on January 1, 2019, allows California farmers to enter the rapidly-growing hemp industry on a wide scale, raising industrial hemp to produce hemp seed, oil, fiber, and extract for a variety of uses. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. or less. (THC

CBD 144

CBD Seed-To-Sale Food Access 144

Green Relief

JANUARY 18, 2018

Due to its non-psychoactive healing properties, Cannabidiol (CBD) has become a very popular option for patients seeking a natural alternative to treat conditions such as chronic pain, anxiety, epilepsy, and more. 3%), resulting in very minimal psychoactive stimulation. Let’s continue!

CBD 56

CBD Cannabinoids Chronic Pain Epilepsy 56

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Healer

JANUARY 17, 2022

These flowers can be extracted to produce products with high levels of CBG that offer distinct medicinal benefits. . People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. People who find CBD and/or CBDA too mentally stimulating.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Healer

JANUARY 17, 2022

These flowers can be extracted to produce products with high levels of CBG that offer distinct medicinal benefits. . People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. People who find CBD and/or CBDA too mentally stimulating.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

WeedAdvisor

APRIL 1, 2019

As anecdotal evidence began piling up, some companies decided that CBD’s reported effects on epilepsy (which has been heavily proven), anxiety, insomnia, pain and inflammation – among others – could work on dogs, cats and other pets. In Canada, CBD extracts come from marijuana. But veterinarians urge caution.

Pets 49

Pets Oil CBD Research and Development 49

Green Relief

JANUARY 18, 2018

Due to its non-psychoactive healing properties, Cannabidiol (CBD) has become a very popular option for patients seeking a natural alternative to treat conditions such as chronic pain, anxiety, epilepsy, and more. 3%), resulting in very minimal psychoactive stimulation. Let’s continue!

Cannabinoids 40

Cannabinoids Chronic Pain CBD Conditions 40

Cannabis Law Report

JULY 12, 2019

However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. The CBD-rich extract group had a lower effective dose on average, 6.1

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. It is the most commonly identified cause of epilepsy among adults. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results.

THC 64

THC CBD Cannabinoids Research and Development 64

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. At the moment, you said that they could potentially add more conditions. IR: Well, today, there is a closed list, basically, of conditions.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. It is the most commonly identified cause of epilepsy among adults. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Healer

JUNE 28, 2019

Cannabinoids have neuroprotective effects, protecting the nerves from acute injuries like head trauma and stroke, and from conditions that cause chronic injury, such as Alzheimer’s disease. OBJECTIVE: To determine the efficacy of medical marijuana in several neurologic conditions. ’ Koppel, Barbara S., Abstract: Medical Study .

Cannabinoids 52

Cannabinoids THC Therapy Patients 52

Freedom Leaf

JANUARY 22, 2019

Section 10113 of the bill removes hemp from the Controlled Substances Act , extracting it from Schedule I status alongside its intoxicating cousin marijuana. Now, hemp is clearly defined as “whole plant,” including extracts, and as cannabis containing less than 0.3 After more than 80 years of prohibition, U.S. percent THC. percent THC.

Retail 68

Retail Legalization Hemp Food 68

StrainConnect

FEBRUARY 8, 2019

Any CBD that is extracted from plants that are classified as cannabis would be considered “Cannabis-Derived CBD.” THC, it would be classified as hemp, and any CBD that is extracted from a plant classified as hemp would be considered “Hemp-Derived CBD. The purity of CBD isolate will depend on the extraction process.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Cannabis Law Report

NOVEMBER 22, 2019

Under the proposed rule, registered organizations will be allowed to use hemp, or extracts derived from hemp, grown and processed under the authority of the New York State Department of Agriculture and Markets in the manufacturing of medical cannabis products. PTSD patients may benefit from cannabis use.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

OCTOBER 17, 2019

Plants with higher THC levels are typically bred and consumed for medical or adult recreational purposes, either in dried form for smoking or with the THC content extracted and infused into foods, beverages, topical ointments, candles, and other products. Hemp has been used for these purposes for centuries in cultures around the world.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

AUGUST 26, 2019

These were moms and dads and grandparents of children [with intractable epilepsy] who were using medical cannabis oils. As in, no to anyone who wasn’t an epilepsy patient.]. The 2017 expansion of Virginia’s medical marijuana law got rid of qualifying conditions. It removed qualifying conditions altogether.

Marijuana 212

Marijuana Legalization Programs Oil 212